DrugsControl Media Services
DrugsControl.org

News Detail

US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)

Maryland, 12 Sept 2024: The U.S. FDA has been a global leader in ensuring drug safety and efficacy, often setting regulatory benchmarks that are followed worldwide. In September 2024, the FDA issued a revised version of its guidance titled View Details

Source : Bioprocess Online
U.S. FDA Control of Nitrosamine Impurities in Human Drugs

Related News